Company profile · Biotech & medical
GenMont Biotech In
景岳生物科技股份有限公司 · 3164
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
GenMont Biotech researches, develops, manufactures, and sells functional probiotic products and engages in the manufacture of western medicines.[1]
Its product lines include Lactobacillus products for allergy, regulation dental care, gastrointestinal health probiotics, and products that improve immunity.[2]
The company also sells other items such as milk powder, other lactic acid bacteria products, and raw materials.[2]
In addition, GenMont Biotech develops agricultural and livestock-related products, daily chemical product ingredients, and functional applications for scalp conditioning and skin care.[2]
The company is based in Tainan City, Taiwan.[1]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$35m | -4.1% | -22.3% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$1m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | GenMont Biotech Incorporation |
|---|---|
| Chinese name | 景岳生物科技股份有限公司 |
| Stock code | 3164 (TWSE) |
| Industry | Biotech & medical |
| Founded | 06 Dec 2000 |
| Listed | 22 Mar 2010 |
| Paid-in capital | NT$860m |
| Chairman | 陳根德 |
| President | 陳昱瑾 |
| Headquarters | NO.8, NAN-KE 7TH RD., SHANHUA DIST,TAINAN SCIENCE-BASED INDUSTRUAL PARK, Tainan City ,Taiwan ,R.O.C. |
| Website | https://www.genmont.com.tw |
| Official business description | 西藥製造業 · 生物技術服務業 · 未分類其他食品製造業 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 景岳生物科技股份有限公司 · mops · retrieved 04 Nov 2026
- Annual report 2025 (English), business scope · annual_report · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list